Back

Galectin-3 level and its relationship with clinical status and instrumental parameters in patients with hypertrophic cardiomyopathy

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiomyopathy Hypertrophic cardiomyopathy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Mrs Alexandra Demkina

Scientific and Practical Clinical Center for Diagnostics and Telemedicine, Moscow (Russian Federation)

33 More presentations in this session

Presentation thumbnail
Left atrium characterization in hypertrophic cardiomyopathy: three-dimensional wall-motion tracking technology as a valuable technique
Doctor L. Marques (Sra. da Hora, PT)
Abstract
Presentation thumbnail
Comparison between LGE-CMR and histomorphometric quantification of myocardial fibrosis in transplanted hearts for end-stage HCM
Doctor G. Galati (Milan, IT)
Presentation thumbnail
Predictors of adverse outcomes and progression of heart failure in patients with hypertrophic cardiomyopathy
Professor A. Kurlianskaya (Minsk, BY)
Abstract
Presentation thumbnail
Chronic heart failure in patients with non-obstructive hypertrophic cardiomyopathy: the effect of the angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
Mrs A. Demkina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Early prognostic factors of left ventricular ejection fraction deterioration in Friedreich ataxia
Doctor L. Legrand (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Cardiomyopathy

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources